[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cellebrite Di Ltd (CLBT)

Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,604,154
  • Shares Outstanding, K 249,440
  • Annual Sales, $ 475,680 K
  • Annual Income, $ 78,330 K
  • EBIT $ 56 M
  • EBITDA $ 65 M
  • 60-Month Beta 1.18
  • Price/Sales 5.84
  • Price/Cash Flow 27.57
  • Price/Book 5.16

Options Overview Details

View History
  • Implied Volatility 61.17% (+4.18%)
  • Historical Volatility 106.71%
  • IV Percentile 59%
  • IV Rank 48.06%
  • IV High 90.44% on 02/05/26
  • IV Low 34.09% on 09/05/25
  • Expected Move (DTE 2) 0.92 (8.35%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 1,875
  • Volume Avg (30-Day) 1,824
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 35,554
  • Open Int (30-Day) 15,951
  • Expected Range 10.08 to 11.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.12
  • Number of Estimates 2
  • High Estimate $0.12
  • Low Estimate $0.12
  • Prior Year $0.08
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.58 +14.82%
on 08/13/26
16.43 -33.05%
on 08/11/26
-4.44 (-28.76%)
since 07/17/26
3-Month
9.58 +14.82%
on 08/13/26
17.05 -35.48%
on 07/07/26
-2.63 (-19.30%)
since 05/18/26
52-Week
9.58 +14.82%
on 08/13/26
19.98 -44.94%
on 11/13/25
-5.16 (-31.93%)
since 08/18/25

Most Recent Stories

More News
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) to Possible Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

CLBT : 11.00 (+5.36%)
BAC : 64.23 (+0.53%)
CLBT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd. (CLBT) shareholders who lost money after the Company's Q2 2026 results and reduced full-year outlook have legal rights -- Levi & Korsinsky is investigating potential securities law violations....

CLBT : 11.00 (+5.36%)
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

CLBT : 11.00 (+5.36%)
BAC : 64.23 (+0.53%)
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd.

Cellebrite DI Ltd. shares dropped over 30% after the Company reported Q2 2026 revenue of approximately $131.1 million and cut its full-year 2026 ARR and revenue guidance -- SueWallSt notifies investors...

CLBT : 11.00 (+5.36%)
Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

Cellebrite DI Ltd. (CLBT) shareholders lost money when the stock sold off more than 30% following the Company's Q2 2026 results -- Levi & Korsinsky is investigating the Company's disclosures concerning...

CLBT : 11.00 (+5.36%)
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Cellebrite DI Ltd.

MILWAUKEE , Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Cellebrite (NASDAQ: CLBT). The investigation results from inaccurate statements Cellebrite...

CLBT : 11.00 (+5.36%)
Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan

Company Reports Second-Quarter 2026 Results ; Company Lowers Full-Year 2026 ARR and Revenue Outlook and Raises Adjusted EBITDA Target

CLBT : 11.00 (+5.36%)
Cellebrite's Genesis AI Monetization Model Gets Its First Real-World Stress Test

Barchart Research What to Expect from CLBT Earnings CLBT Generated August 12, 2026 Current Price $15.25 EPS Estimate $$0.09 Consensus Rating Strong Buy Average Move 7.00% Cellebrite's Genesis AI Monetization...

CLBT : 11.00 (+5.36%)
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows

Cellebrite DI (NASDAQ:CLBT) executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal authorization...

CLBT : 11.00 (+5.36%)
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth

Cellebrite DI (NASDAQ:CLBT) executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial intelligence...

CLBT : 11.00 (+5.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors. Cellebrite DI Ltd., formerly known as TWC Tech Holdings II Corp., is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 11.97
2nd Resistance Point 11.51
1st Resistance Point 11.25
Last Price 11.00
1st Support Level 10.53
2nd Support Level 10.07
3rd Support Level 9.81

See More

52-Week High 19.98
Fibonacci 61.8% 16.01
Fibonacci 50% 14.78
Fibonacci 38.2% 13.55
Last Price 11.00
52-Week Low 9.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.